CareTrust REIT: The Blueprint of the Triple-Net Operator-First Model

I. Introduction: The $10 Billion Balance-Sheet Paradox

There is a number in CareTrust REIT's first-quarter 2026 disclosures that looks like a typographical error.

Net debt to annualized normalized run-rate EBITDA: 0.6x.¹

For anyone who has spent time around real estate investment trusts, that figure does not compute. REITs are, by construction, leveraged vehicles. They exist because real estate throws off predictable cash flows that can support debt, and because the U.S. tax code lets a REIT skip corporate income tax so long as it distributes essentially all of its taxable earnings to shareholders. Retained earnings are therefore not really an option. Growth has to be funded externally — with debt, with equity, or with both. The industry's answer for four decades has been debt, and the healthcare REIT peer group has settled into a comfortable band somewhere between three and five and a half turns of EBITDA. Omega Healthcare Investors, the largest pure-play skilled nursing landlord in America, reported leverage of roughly 3.5x in the same quarter. Sabra Health Care REIT reported 5.04x.²³

CareTrust reported 0.6x. Net debt to enterprise value was approximately 3.6%.¹ In plain English: a company that owns hundreds of nursing homes and care facilities across thirty-two American states and the United Kingdom has almost no net debt at all. Its own stated long-term target leverage range is 4.0x to 5.0x — meaning management is running the balance sheet at roughly one-seventh of where it says it eventually intends to run it.

This is not a company that failed to lever up. It is a company that chose not to, and the choice has been the single most consequential capital allocation decision in its twelve-year history.

The results have been striking. Total revenues reached $476.4 million for the full year 2025, up from $296.3 million the year before.⁴ The first quarter of 2026 alone produced $142.8 million of revenue, a run-rate that annualizes to roughly $571 million — nearly double the 2024 full-year figure in a little over a year.¹ Normalized funds from operations, the REIT industry's preferred earnings measure, grew 38% in absolute dollars year over year in Q1 2026 to $107.4 million, and 14% on a per-share basis to $0.48.¹ That gap between the absolute and per-share growth rates is the entire story of this company compressed into two numbers, and we will spend a good deal of this piece unpacking it.

Around mid-July 2026 the stock traded near $42 per share, giving CareTrust a market capitalization in the neighborhood of $10 billion against a guided diluted share count of roughly 234 million.¹ On the raised 2026 guidance midpoint of about $2.02 of normalized FFO per share, that is a multiple in the low twenties — a premium to essentially every comparable healthcare REIT in the market.¹

The origin secret

The paradox has an origin, and the origin is a spin-off.

On June 1, 2014, The Ensign Group — a Mission Viejo, California skilled nursing operator with a cult-like internal culture and a reputation for turning around broken nursing homes — separated its real estate from its operations and set the property company loose as an independent, publicly traded REIT.⁵ CareTrust began life with one meaningful tenant and eight master leases, all of them signed with its former parent. Ensign affiliates were, for practical purposes, the entire business.

Twelve years later, Ensign master leases accounted for roughly 23% of CareTrust's total annualized contractual rent at the end of 2025 — still the largest single relationship by a wide margin, but no longer the company.⁴ In between sits a story of disciplined acquisition, at least four significant tenant failures that the company rarely volunteers, a leadership handoff, an $840 million transatlantic acquisition, and a deliberate refusal to use the cheapest form of capital available to a real estate company.

What we are testing

The bull case on CareTrust is easy to state and harder to verify. It goes: the company's founders and executives actually ran nursing homes, so they underwrite operators better than financial buyers do; better operators produce better rent coverage; better rent coverage produces fewer defaults; fewer defaults produce a premium equity valuation; and a premium equity valuation lets the company issue stock cheaply and buy properties at high yields, which produces per-share growth, which sustains the premium. It is a flywheel, and management describes it as one.

The bear case is equally easy to state. The flywheel runs on the stock price. If the multiple compresses, the arbitrage narrows, the growth slows, and the multiple compresses further. Meanwhile the underlying assets are nursing homes whose economics are set in state Medicaid budget offices and federal reimbursement rules, over which CareTrust has precisely zero control.

Both are worth taking seriously. What follows traces the Ensign inheritance, the mechanics of triple-net healthcare underwriting, the messy middle years that the tidy version of this story tends to skip, the capital structure that makes the whole thing work, the competitive position tested against Porter and Helmer, the risks that could break it, and the two or three metrics that will tell an investor whether the machine is still running. We begin where CareTrust began: inside somebody else's company.

---

↑ Back to Top

II. The Ensign Group Genesis & Spinoff

To understand CareTrust, you first have to understand a piece of corporate architecture that sounds almost like a joke: The Ensign Group does not have a headquarters.

It says so in its own filings. "We do not maintain a corporate headquarters," the company wrote in its annual report; "rather, we operate a Service Center to support the efforts of each operation."⁶ The Service Center — a nondescript office suite in Mission Viejo, California — provides information technology, human resources, accounting, payroll, legal, risk management and training. What it explicitly does not do is run the nursing homes.

The heresy

That distinction was, in the context of the skilled nursing industry circa 1999, close to heresy.

Ensign was incorporated in Delaware in 1999 by Roy E. Christensen — a long-term care veteran with roughly five decades in the sector who had founded Covenant Care in 1994 — together with his son Christopher Christensen and four others.⁶⁷ Among the founding group was Gregory K. Stapley, a real estate and business transactions lawyer who became Ensign's general counsel and later an executive vice president.⁸ Christopher Christensen became chief executive in 2006.⁷

The industry they entered was consolidating around a familiar model: buy nursing homes, centralize purchasing and staffing decisions at corporate, extract scale economies, repeat. The trouble was that nursing homes are intensely local businesses. The quality of a facility depends on whether the administrator can hire and retain nurses in a specific labor market, whether the local hospital's discharge planners trust the building enough to send patients there, and whether state surveyors leave satisfied. None of those things is improved by a policy memo from three states away.

Ensign's answer was to invert the hierarchy. Local leaders, the company wrote, "operate as separate local businesses. With broad local control, these talented leaders and their care staffs are able to quickly meet the needs of their patients and residents, employees and local communities, without waiting for permission to act or being bound to a 'one-size-fits-all' corporate strategy."⁶ Facilities were grouped into geographically proximate "clusters" and "markets" that shared clinical best practices and real-time financial data. A New Market CEO program, established in 2006, relocated proven leaders into target geographies to build businesses from scratch. An in-house training system, Ensign University, produced the pipeline of facility CEOs.⁶

The strategic payoff was specific: it made Ensign unusually good at buying broken buildings. "Much of our historical growth," the company stated plainly, "can be attributed to our expertise in acquiring real estate or leasing both under-performing and performing post-acute care operations and transforming them into market leaders in clinical quality, staff competency, employee loyalty and financial performance."⁶ Ensign went public on NASDAQ in November 2007 and spent the following years compounding through exactly that turnaround motion.

By the early 2010s the company had a problem common to successful operators: it owned a great deal of real estate, and the public market was valuing that real estate at an operating-company multiple rather than a real estate multiple. The fix was structural.

June 1, 2014

CareTrust REIT, Inc. was formed as a wholly owned Ensign subsidiary on October 29, 2013.⁹ On June 1, 2014, Ensign completed the separation of its healthcare business and its real estate business into two separate and independent publicly traded companies, with shares distributed to Ensign holders on a one-for-one basis to shareholders of record as of May 22, 2014.⁹⁵

Stapley, the lawyer who had helped found Ensign and spent roughly fourteen years inside it, became CareTrust's founding chairman and chief executive.⁸ William M. Wagner — previously chief accounting officer at both Nationwide Health Properties, a healthcare REIT, and Sunstone Hotel Investors — became chief financial officer.⁹ A licensed nursing home administrator named David M. Sedgwick joined as vice president of operations.⁹ Keep that last name in mind.

The financial engineering was straightforward and, from Ensign's perspective, highly effective. In late May 2014 CareTrust subsidiaries completed a private offering of $260.0 million of 5.875% senior notes due 2021, priced on May 16.¹⁰ Roughly $221 million of the net proceeds went to Ensign, to repay indebtedness, settle trade payables and support dividends.⁹ Ensign, in other words, extracted several hundred million dollars of cash from real estate it had been carrying at depreciated book value, and retained an operating business now unburdened by property ownership. This is the mechanism by which spin-offs unlock value: the same assets, rearranged, get valued by different buyers on different multiples.

CareTrust also had a piece of housekeeping unique to REIT conversions. To qualify as a REIT it had to distribute the accumulated earnings and profits allocated to it in the separation. The board declared this "purging distribution" on October 17, 2014 — $132.0 million, roughly $5.88 per share, paid on December 10, mostly in stock, resulting in the issuance of nearly nine million new shares.⁹ It was a one-time cost of admission to the tax structure, and it diluted early holders considerably.

The golden handcuffs

The portfolio that walked out the door was, on a pro forma basis as of March 31, 2014, 97 properties — of which 94 were leased to Ensign, comprising 10,121 operational beds and units across ten states.⁹ CareTrust itself directly operated three independent living facilities with 264 units, a small legacy oddity.

Those 94 properties were organized into eight triple-net master leases, each with its own pool of properties and staggered maturities, initial terms in excess of ten years, and two or three five-year renewal options exercisable by the tenant.⁹ Initial annual rent was $56.0 million in each of the first two years, escalating from June 1, 2016 by the lesser of CPI or 2.5%. Critically, there were no purchase options — Ensign could not buy the buildings back — and the leases were guaranteed by The Ensign Group itself.⁹

The master lease structure deserves a moment, because it is the load-bearing wall of this entire business model. In a single-property lease, a tenant operating a struggling facility can simply hand the keys back and walk away, leaving the landlord with an empty, licensed, highly specialized building. In a master lease, a pool of facilities sits under one contract with one rent obligation and one guarantor. The tenant cannot cherry-pick — it cannot keep the four profitable buildings and abandon the two weak ones. To exit any, it must default on all, which means surrendering the profitable buildings too. The structure converts a portfolio of individually fragile assets into a single, considerably more durable obligation.

For CareTrust in 2014, that structure was the difference between a bond-like income stream and a genuinely speculative one. Reported lease coverage on the Ensign master leases ran around 2.07x in the first full year — meaning tenant-level earnings before rent were roughly double the rent owed.⁹

But safety and concentration were the same thing. In the fourth quarter of 2014, Ensign accounted for approximately 95% of CareTrust's revenues.¹¹ Christopher Christensen sat on CareTrust's board from the separation until April 15, 2015, a reminder of how tight the umbilical remained.⁹ Every equity analyst covering the name asked the same question: what is this, other than a leveraged bet on one operator's continued health?

The mandate was therefore set on day one, and it was not subtle. Use the reliable Ensign cash flow as a foundation. Buy non-Ensign properties. Bring the concentration down. Do it without buying garbage.

What nobody said out loud in 2014 was how hard the third part would prove to be.

---

↑ Back to Top

III. The Triple-Net (NNN) Healthcare Model & Underwriting Economics

Picture two spreadsheets on the same building.

The first belongs to the operator running a 120-bed skilled nursing facility in suburban Ohio. It is a mess of moving parts: Medicaid per-diem rates set by the state legislature, Medicare Part A rates set by federal rulemaking, a Medicare Advantage plan negotiating shorter lengths of stay, agency nursing costs that spiked during the pandemic and never fully retreated, food inflation, liability insurance, state survey deficiencies that can trigger admission holds, and a census that swings with the local hospital's discharge patterns.

The second belongs to CareTrust. It has one line: rent.

What triple-net actually means

That is the essence of the triple-net lease, and it is worth being precise about it because the term gets used loosely. In a triple-net structure, the tenant bears the three "nets" — real estate taxes, building insurance, and maintenance — plus, in the healthcare version, essentially all capital expenditures and every facility-level operating cost. The landlord's obligations approach zero. There is no leasing team, no property management staff, no common-area maintenance, no re-tenanting cost on a five-year cycle.

The economic consequence is a margin structure that looks nothing like a shopping center or an office tower. Rental income converts to cash flow at a very high rate, and it does so predictably, with contractual annual escalators built in. CareTrust's 2026 guidance assumed 2.5% inflation-based rent escalators under its long-term triple-net leases — a modest, contractual, compounding step-up that requires no negotiation and no capital.[^12]

The trade-off is equally clean. A triple-net landlord gives up all operating upside. If a facility's margins double, the landlord still collects the same rent plus 2.5%. All the operating leverage — and all the operating risk — sits with the tenant. Which means the landlord is not really underwriting a building. It is underwriting a counterparty.

The volatile ground underneath

And the counterparties operate in one of the most reimbursement-dependent industries in the American economy.

Medicaid accounts for roughly 59% of skilled nursing facility patient days nationally, with Medicare around 11% and private pay and other sources making up the balance.¹² That mix is the single most important fact about the sector. Medicaid is a state-administered, jointly funded program whose per-diem rates are set through state budget processes. Medicare pays materially better but covers only short post-acute stays. A nursing home's profitability is therefore substantially a function of political decisions made in fifty state capitals and one federal one.

Two recent developments illustrate how violently that ground can move — in both directions.

The first went the operators' way. In April 2025, the U.S. District Court for the Northern District of Texas struck down the Centers for Medicare & Medicaid Services' minimum staffing rule, which would have required 24/7 registered nurse coverage and a national minimum of 3.48 nursing hours per resident day, holding that CMS had exceeded its statutory authority.¹³ The federal government withdrew its appeals later that year, and CMS moved to formally repeal the requirements in December 2025.¹⁴ The One Big Beautiful Bill Act, signed in July 2025, layered on a ten-year moratorium on the mandate.¹⁵ For an industry facing a nursing shortage, this removed what would have been a very large, very permanent cost increase.

The second cut the other way. The same legislation began phasing down the Medicaid provider-tax "hold harmless" threshold from 6% to 3.5% in expansion states, in half-point annual steps beginning in fiscal 2028, while freezing new or increased provider taxes and capping state-directed payments.¹⁵ Provider taxes are a mechanism states use to draw down additional federal Medicaid matching funds, some of which flows back to nursing homes as supplemental payments. Constraining them constrains state capacity to fund nursing home rates. The effects are deferred to 2028 and beyond and will vary enormously by state, but they represent a genuine, legislated headwind to the revenue line of CareTrust's tenants. It is not a risk the company can hedge, diversify away, or manage. It can only underwrite for it by demanding a large cushion.

The Certificate of Need question — and a useful correction

The standard bull argument for skilled nursing real estate invokes Certificate of Need laws. The premise is that in most states, you cannot simply build a nursing home; you must first persuade a state agency that the community "needs" additional beds. Supply is therefore administratively rationed, existing licensed beds are scarce, and the value of an operating facility is protected from new competition.

The premise is broadly accurate. As of 2025, thirty-five states plus the District of Columbia operated formal CON programs, with several additional states running CON-like approval processes; roughly thirty-four applied CON requirements to nursing homes specifically.¹⁶ Twelve states had fully repealed their programs or allowed them to lapse.¹⁶ Independent research has found that CON regimes measurably slowed the growth of nursing home bed supply.¹⁷ Combined with post-pandemic capacity attrition — a meaningful number of facilities closed between 2019 and 2024 and were never replaced — the effect on existing assets has been real.

But here is a detail worth flagging, because it is the kind of thing that separates a marketing deck from an honest read. CareTrust's own annual report does not characterize CON as a competitive moat. It characterizes it as a risk. The filing notes that the ability to obtain CON approval "may impact some of our tenants', managers', and borrowers' abilities to expand or change their businesses," and in a risk factor observes that delays in change-of-ownership CON approvals have "in the past prolonged, and may in the future prolong, the period during which we are unable to collect rent."⁴

That is the underappreciated flip side. The same regulatory friction that keeps competitors out also keeps CareTrust trapped when a tenant fails. Replacing a defaulted operator is not a matter of signing a new lease; it requires state licensure transfer, and that process can take months during which the building generates nothing. The moat has a moat problem.

Underwriting the operator, not the building

Which brings us to the metric that matters more than any other in this sector: EBITDAR coverage.

The concept is simple once you strip the acronym. Take a facility's earnings before interest, taxes, depreciation, amortization — and rent. That is the pool of cash available to pay the landlord. Divide it by the rent owed. A coverage ratio of 1.0x means the tenant earns exactly enough to pay rent and nothing else — no profit, no cushion, no room for a bad quarter. A ratio of 1.3x means a 23% decline in facility earnings wipes out the entire margin of safety.

Skilled nursing operators historically run thin. Coverage in the 1.2x to 1.5x range has been common across the sector, and Omega Healthcare — the closest large-cap comparable — reported trailing coverage of roughly 1.57x on its core portfolio in early 2026.² There is a related measure, EBITDARM, which adds back management fees; it always reads higher and is not directly comparable, which is worth remembering when peers quote different acronyms.

CareTrust reported stabilized triple-net portfolio EBITDAR coverage of 2.25x and EBITDARM coverage of 2.79x in the first quarter of 2026.[^12] On the earnings call, chief executive Dave Sedgwick described the portfolio's coverage as "very strong" and noted that the company collected 100% of contractual rent and interest in the quarter.[^12]

A cushion of that size is the most concrete evidence available for the operator-first thesis. At 2.25x, tenant-level earnings can fall by more than half before rent becomes unaffordable. That is not a rounding-error advantage over a peer at 1.57x; it is a structurally different risk profile, and it is the single number that most justifies a premium valuation.

Two caveats belong alongside it. First, "stabilized" is doing work — the metric excludes recently acquired and transitioning assets, which is standard practice but means the reported figure describes the seasoned book rather than the whole portfolio. Second, high coverage is partly a function of when CareTrust bought. Assets acquired at attractive bases with rents set conservatively will show good coverage almost by construction; the test is whether coverage holds as the company deploys capital at record pace into a more competitive market.

Management's claim is that the operator selection itself is the edge. On the Q1 2026 call, Sedgwick disclosed preliminary results of an internal study comparing publicly reported CMS quality outcomes at CareTrust-leased skilled nursing facilities against sector averages, limited to facilities under lease for at least four years so star ratings could adjust to the new operator. The preliminary findings, he said, showed CareTrust tenants achieving higher overall and health-inspection star ratings than for-profit operators generally, and higher quality-measure ratings, lower rehospitalization rates and higher successful discharge rates than all operators including non-profits.[^12]

That is an interesting and specific claim, and if it holds up under external scrutiny it would be meaningful evidence that operator selection is a repeatable skill rather than a story. It is also, at this stage, a self-reported preliminary internal analysis with a selection criterion chosen by the company. Investors should treat it as a hypothesis worth watching rather than a proven fact.

The harder evidence lies in what happened when CareTrust's underwriting actually failed — which it did, repeatedly, in the years nobody puts in the investor deck.

---

↑ Back to Top

IV. Post-Spinoff Playbook: The Great Diversification (2014 – 2022)

The tidy version of the diversification story is a straight line: 95% Ensign concentration in 2014, low twenties today, mission accomplished.

The actual line is not straight. It falls off a cliff, flattens, and then goes back up.

Here is the sequence, drawn from the company's own annual filings, with the caveat that CareTrust changed its measurement basis over the years — from revenues, to rental income, to total annualized contractual rent — so the series is directionally reliable rather than precisely continuous. Ensign represented approximately 95% of fourth-quarter 2014 revenues, then 81% in 2015, 58% in 2016, 44% in 2017, 41% in 2018, and 38% in 2019.¹¹⁴ Then it stopped falling. It sat at 32% for 2020 and 2021 — and then rose to 35% in 2022.⁴

Concentration going up in a company whose founding mandate was to bring it down is not a rounding artifact. It is a signal. And what it signals is that between roughly 2017 and 2022, CareTrust spent a great deal of energy not acquiring but repairing.

The first big bet, and the first big failure

The deal that broke the initial concentration was the Liberty portfolio: fourteen skilled nursing facilities in Ohio, acquired October 1, 2015 for approximately $176.5 million and leased to Pristine Senior Living under a new fifteen-year triple-net master lease at $17.0 million of initial annual rent, guaranteed by Pristine and two of its principals.¹⁸⁹

It was, by design, the template. Off-market or lightly marketed. Regional scale. A single new operating relationship taking an entire portfolio under one master lease. A yield well above what the large diversified REITs were paying. This was CareTrust's strategic positioning in miniature: while Welltower and Ventas competed for institutional-quality senior housing portfolios at compressed cap rates, CareTrust hunted mid-sized skilled nursing deals where relationships mattered more than auction processes and yields ran materially higher.

Then it fell apart.

By the third quarter of 2017 CareTrust was deferring Pristine's rent. A fourth lease amendment in November 2017 restructured roughly $0.8 million of deferred September base rent into monthly installments with a balloon due in 2023.⁹ Pristine then paid only $4.4 million of the $4.9 million of base rent due under the amended terms and missed a further $2.3 million of required payments.⁹ CareTrust put the tenant on a cash-only plan, then gave up: a lease termination agreement was signed in February 2018, and effective May 1, 2018 the remaining facilities were transferred — seven to Trio Healthcare and two to Hillstone Healthcare — after seven Cincinnati-area facilities had already been handed to Trillium Healthcare effective December 1, 2017.¹⁹⁹

Three years from marquee acquisition to complete operator replacement. That is the real duration risk in this business, and it is not visible in a lease document that says fifteen years.

The replacements failed too

What makes the period genuinely instructive is that the rescue operators also struggled.

Trillium was found to lack the regional operating knowledge the assets required; in September 2019 CareTrust sold three of the Ohio properties for $28.0 million and re-leased the remaining four to affiliates of the Providence Group.⁴ Trio, having taken over buildings that included one carrying a federal Special Focus Facility designation, required a substantial rent reduction and was eventually exited entirely — CareTrust completed the sale of the seven-facility Ohio portfolio for $52 million and terminated the Trio master lease on September 30, 2022.²⁰²¹

Elsewhere, Metron Integrated Health Systems, which had entered into a roughly $41.5 million sale-leaseback of five Grand Rapids properties in March 2018, faced repayment demands on improper Medicaid payments, told CareTrust it would vacate and stop paying rent; the six Michigan facilities were sold in February 2020 for $36.0 million, with CareTrust providing a $32.4 million short-term mortgage loan at 7.5% to get the transaction done.⁴ And in September 2021, CareTrust amended two master leases with Noble affiliates to defer $1.8 million of unpaid base rent, roughly 4% of quarterly contractual base rent, and agreed to purchase two Noble-owned assisted living facilities — the deferred amounts were subsequently paid in full.²² Noble's care quality at certain facilities drew critical press attention during the same period.²³

The reckoning came in February 2022, when CareTrust announced a repositioning plan covering 32 of its 228 assets, representing roughly 10% of contractual cash rent. Twenty-seven were designated for sale and three repurposed, and the company recorded approximately $59.7 million of aggregate impairment in the first quarter of 2022, with held-for-sale assets ballooning to $141.7 million.²⁴

That is the honest accounting of the diversification decade: roughly one in seven properties, by count, had to be cleaned up.

What the failures actually prove

It would be easy to read this as an indictment. It is more interesting read as evidence about what the operator-first model does and does not deliver.

What it did not deliver was superior tenant selection in the early years. CareTrust picked Pristine, Trillium, Metron and Noble, and all four disappointed. Operating experience did not confer clairvoyance.

What it did deliver was speed and competence in the workout. Look at the pattern: in every case, CareTrust replaced the operator, sold the assets, or restructured the lease within a few quarters of the problem surfacing — and in several cases used its own balance sheet to bridge the transaction. There were no multi-year litigation sagas, no protracted bankruptcy proceedings dragging rent to zero indefinitely. A landlord that knows which regional operators can actually run a building in Dayton, and that can pick up the phone and get one there, converts a potential catastrophe into a bad two years. That is a genuine, if unglamorous, form of operating advantage, and it is more credible than the tenant-selection claim because it was tested repeatedly.

It is also why 2022 concentration went up. Ensign's share rose not because CareTrust bought more Ensign properties but because it shed non-Ensign rent faster than it added new relationships. Acquisition volume in 2022 was roughly $21.9 million — essentially a pause year — after a 2020 slowdown to about $89.8 million during the pandemic.⁴

The pandemic itself, incidentally, was a notable non-event for CareTrust. The company collected 99.3% of contract rents in April 2020, and unprecedented federal aid flowed to nursing home operators.²⁵ The stress test everyone feared in March 2020 never materialized; the stress that mattered had already happened, tenant by tenant, in the years before.

By the end of 2022 the portfolio stood at 216 properties — actually fewer than the 227 of the year before.⁴ What CareTrust had, coming out of that period, was a cleaner book, a proven workout playbook, a balance sheet unencumbered by the debt that a more aggressive acquirer would have carried into a rising-rate environment, and a new chief executive.

---

↑ Back to Top

V. Dave Sedgwick & Modern Management: "Operator-First" DNA

There is a phrase Dave Sedgwick used on the first-quarter 2026 earnings call that is worth pausing on, because executives of $10 billion companies do not usually say things like it.

"Many of you know I am a recovery nursing home administrator," he told analysts. "Several of us here have many years of experience inside the buildings."[^12]

It is a joke with a point. The point is that the chief executive of this REIT once ran the kind of asset the REIT now owns — not as an asset, but as a business with residents in it.

The résumé

Sedgwick is a licensed nursing home administrator. He joined The Ensign Group in 2001 and from 2002 to 2007 operated three of its skilled nursing facilities across two states. From 2007 to 2012 he served as Ensign's President of Facility Services and Chief Human Capital Officer — running, among other things, the facility-CEO training program at Ensign University, the mechanism by which the decentralized model reproduced itself. In 2012 he moved to lead Ensign's Doctors Express urgent care franchise business, and in 2013 supported its Colorado skilled nursing operations. He holds an accounting degree from Brigham Young University and an MBA from the University of Southern California.²⁶

He joined CareTrust at its formation in 2014 as vice president of operations, became chief operating officer in August 2018, president in February 2021, and succeeded Stapley as chief executive effective January 1, 2022 — an appointment announced the prior December.²⁶²⁷ He joined the board in mid-2022.²⁸

Note what that path is not. It is not an investment banking track, not a REIT capital markets track, not an external hire brought in to professionalize a founder-led company. It is a nine-year internal apprenticeship at the REIT preceded by thirteen years inside the operator. Sedgwick spent the Pristine collapse, the Trillium exit, the Metron departure and the 2022 repositioning as the company's chief operating officer. He inherited a company whose problems he had personally worked on.

The bench, and the pattern in it

The rest of the senior team follows a recognizable pattern.

James "Jamie" Callister, the chief investment officer, came from the other side of the table — roughly two decades as a real estate attorney, at O'Melveny & Myers and later as a partner at Sherry Meyerhoff Hanson & Crance, focused from 2008 on healthcare REIT transactions. He served as CareTrust's general counsel from February 2021 and was named chief investment officer effective December 31, 2022, succeeding Mark Lamb.²⁹

Derek Bunker became chief financial officer on January 1, 2026. His path is the most telling: attorney at Latham & Watkins, then vice president of acquisitions and business legal affairs at The Ensign Group from 2015 to 2019, then chief investment officer of The Pennant Group — itself an Ensign spin-off — from 2019 to 2022. He joined CareTrust in June 2025 as senior vice president of strategy and investor relations before being named CFO successor that September.³⁰³¹

He replaced Bill Wagner, who had been chief financial officer continuously since the 2014 separation — an eleven-year tenure spanning the entire diversification decade, announced as a planned retirement rather than a departure.³⁰ Orderly CFO successions with a six-month overlap are a modest but real governance positive; abrupt CFO exits at acquisitive companies are one of the more reliable warning signs in public markets, and this was the opposite of that.

And in October 2025, CareTrust announced that Greg Stapley would rejoin the board effective January 1, 2026, expanding it from five to six directors.³² Stapley had stepped down as executive chairman in mid-2022, with Diana Laing becoming chair, and left to serve a multi-year full-time volunteer mission for the Church of Jesus Christ of Latter-day Saints.²⁸ His return brings the founder's institutional memory back to the boardroom four years on.

The consistent thread across all of it is the Ensign alumni network — Sedgwick, Bunker, Stapley, and the broader relationship web that sources deals. It is a genuine asset. It is also a concentration of a different kind: a leadership group drawn heavily from one company's culture, with the attendant risk that shared assumptions go untested. Investors who value cognitive diversity on boards may find a six-person board with deep founder ties a fair subject for challenge.

Testing credibility against behavior

The interesting question is not whether management sounds credible. It is whether its behavior has matched its statements over time.

On the central claim — capital discipline — the record supports management. Through the 2021–2023 period, when interest rates rose faster than at any point in four decades and many REITs found themselves with debt maturities they could not economically refinance, CareTrust did not lever up chasing volume. It paused acquisitions, cleaned up its tenant book, and waited. It did not, in its public commentary, attribute its slow years primarily to macro conditions. When the market reopened, it funded growth with equity rather than debt. Consistency between stated philosophy and actual balance sheet behavior across a full rate cycle is meaningful evidence, and it is more than many peers can show.

On guidance discipline, the recent record is one of raising rather than missing. Initial 2026 normalized FFO guidance issued in February was $1.90 to $1.95 per share; by May it had been raised to a range whose midpoint, roughly $2.02, represented an increase of about 4.9% versus the original range and about 14.8% over 2025 results.[^12]⁴ Guiding conservatively and raising is a defensible practice — though sustained, repeated beats also invite the question of whether initial guidance is set deliberately low, and investors should watch whether the pattern persists once growth normalizes.

Compensation is structured around long-term alignment, with performance-based restricted stock units tied to relative total shareholder return and normalized FFO per-share growth.²⁶ That construction is worth a moment of scrutiny. FFO-per-share growth is the correct metric for a company whose entire strategy is accretive external growth — it cannot be gamed by simply issuing more equity, since the denominator moves too. But it also does not capture underwriting quality, which shows up years later in coverage ratios and impairments. A management team paid on FFO per share and relative TSR has a mathematical incentive to keep the acquisition machine running. That incentive is aligned with shareholders in good markets and potentially misaligned at exactly the moment discipline matters most.

There is a second-order observation buried in the Q1 2026 call. Asked about rising general and administrative expense guidance, Bunker attributed the increase "almost entirely" to hitting key performance indicators for short-term incentive compensation, given performance and investment spend to date, plus continued team build-out.[^12] The answer was direct and specific rather than deflective — a small but genuine marker of disclosure quality.

Where management has been notably candid is on competition. Asked by an analyst whether building the senior housing operating platform had proven harder than expected, Sedgwick acknowledged surprise — specifically "to see how aggressive some of our competitors' underwriting has been," noting that CareTrust sometimes loses deals to bidders without its cost-of-capital advantage.[^12] Admitting you are being outbid by less well-capitalized competitors is not the standard IR answer, and it is more useful information than a claim of superiority would have been.

That cost of capital is the next thread, and it is the one that makes everything else possible.

---

↑ Back to Top

VI. Capital Allocation & The Equity Funding Engine

Every REIT is, underneath the property portfolio, an arbitrage machine. It raises capital at one price and deploys it into assets yielding another price. The gap is the business. Everything else — the buildings, the leases, the tenants — is machinery for harvesting a spread.

What makes CareTrust unusual is which side of the capital structure it harvests from.

The mechanics, plainly

The conventional REIT playbook uses debt. Borrow at 5%, buy at 7%, capture two points of spread, magnified by leverage. It works beautifully until rates rise or credit markets close, at which point the maturity wall becomes an existential problem and the growth engine stalls precisely when distressed assets become cheapest.

CareTrust runs the equity version. Its stock trades at a premium multiple; on the raised 2026 guidance the FFO yield — annual funds from operations divided by share price — sits somewhere near 4.8%. That is the approximate economic cost of issuing a share. Against that, the company deployed capital in the first quarter of 2026 at a blended stabilized yield of 8.8%, and roughly $865 million more across twelve transactions since April at a blended stabilized yield of approximately 8.9%.[^12]

Four points of spread, funded with permanent capital that never matures, never needs refinancing, and cannot be called in a credit crisis.

That is why absolute normalized FFO grew 38% year over year in the first quarter while per-share FFO grew 14%.¹ The share count expanded substantially — but the earnings expanded faster. Issuing equity is only dilutive if what you buy earns less than what you paid for the money. When the gap runs four points wide, issuance is the growth engine rather than a tax on it.

What they actually did

The financing history shows this executed at scale. In August 2025, CareTrust priced an upsized public offering of 20 million shares at $32.00, with a 3 million share underwriter option — roughly $640 million base, approximately $736 million if fully exercised.³³ A $500 million unsecured term loan was put in place in 2025 to support the UK entry.³¹ In May 2026 the company priced a further upsized offering of 12.5 million shares, plus a 1.875 million share option, on a forward sale basis at $40.225 per share — roughly $509 million.³⁴

The forward structure in that most recent raise is a small piece of financial craftsmanship worth explaining. In a forward sale, the company agrees to sell shares at today's price but does not actually issue them — and does not receive the cash — until it chooses to settle, typically within a year. It locks in the price without diluting anyone until the money is needed. For an acquirer with a pipeline of deals at uncertain closing dates, it eliminates the awkward choice between issuing early and sitting on idle cash, or issuing late and risking a lower price. CareTrust also runs an at-the-market program, which drip-feeds shares into the market on a continuous basis; it settled $129.5 million of gross proceeds under its ATM forward program in the first quarter of 2026 alone.[^12]

The resulting balance sheet, as of the May 2026 update: $350 million drawn on a $1.2 billion unsecured revolving credit facility, approximately $70 million of cash, $850 million of revolver availability, roughly $879 million of remaining ATM capacity, and no scheduled debt maturities before 2028.[^12] Add it up and the company had well over $1.7 billion of immediately accessible capital against essentially no net debt.

The ratings, and what they signal

The credit agencies validated the structure. Fitch Ratings upgraded CareTrust to investment grade BBB- in May 2025, and Moody's followed with an upgrade to Baa3 in April 2026, moving its outlook from positive to stable.³⁵³⁶ Dual investment-grade ratings open the unsecured bond market on institutional terms.

Bunker told analysts the company was exploring an inaugural high-grade issuance, and when pressed on pricing indicated that a ten-year deal would likely price at roughly 130 to 140 basis points over the benchmark.[^12] Asked whether CareTrust might issue in sterling to naturally hedge its UK exposure, he said any near-term issuance would be dollar-denominated, reasoning that continued UK acquisition activity — buying pounds while short dollars — already provides a partial natural hedge.[^12]

This is the point at which the fortress balance sheet stops being merely conservative and becomes strategic. A company with 0.6x leverage and investment-grade access has an option that its peers do not: it can lever up. Moving from 0.6x toward the stated 4.0x to 5.0x target would fund several billion dollars of acquisitions without issuing a single share. That optionality has real value, and it is worth more in a dislocated market than in a benign one.

The dividend rounds out the picture. CareTrust raised its quarterly dividend to $0.39 per share in early 2026, a 16.4% increase and the tenth consecutive annual raise, representing roughly an 81% payout of normalized funds available for distribution.³⁷ For a REIT that must distribute most of its taxable income anyway, an 81% FAD payout leaves modest retained cash — the growth is funded externally by design.

The honest reading

There is a temptation to describe this as risk-free growth. It is not.

The arbitrage is entirely dependent on the equity multiple, and the equity multiple is set by a market that can change its mind. If CareTrust's shares were to trade down materially, the FFO yield would rise, the spread against 8.9% acquisitions would narrow, and each new share issued would deliver less accretion. At a sufficiently low price, issuing equity to buy assets stops creating value. The machine does not break loudly; it just quietly stops compounding. This is not a hypothetical — it is the ordinary experience of most net lease REITs most of the time. CareTrust's current position is a good one, not a permanent one.

There is also a subtler critique available to a skeptical investor: a company growing revenue this fast through continuous equity issuance is difficult to evaluate on conventional metrics, because the denominator is always moving and newly acquired assets have not yet been tested through a full cycle. Reported coverage, occupancy and credit quality all reflect a portfolio that is, on average, quite young. That is not evidence of a problem. It is a reason to demand more evidence before extrapolating.

Which raises the question the next section addresses directly: is any of this actually defensible, or is CareTrust simply a well-run company enjoying a favorable moment?

---

↑ Back to Top

VII. Porter's 5 Forces & Hamilton Helmer's 7 Powers

Strategy frameworks are most useful when they force uncomfortable questions. Applied honestly to CareTrust, they produce a split verdict: the industry structure is genuinely attractive, and the company-specific advantages are narrower than the narrative suggests.

Porter's Five Forces

Threat of new entrants: low, but for unromantic reasons. The barriers are real and stack: Certificate of Need regimes in most states restrict new bed supply; construction costs and interest rates have made ground-up skilled nursing development largely uneconomic; and — most binding of all — the constraint is not capital but licensed, competent operators. Anyone can buy a nursing home. Very few can run one well, and a landlord without a stable of qualified tenants owns a licensed building it cannot legally operate. That said, the barrier protects the asset class broadly, not CareTrust specifically. Capital has been arriving: family offices and private buyers compete aggressively for skilled nursing assets, and Callister described the U.S. skilled nursing market as one where "you have a lot of family office and fierce competition."[^12]

Bargaining power of tenants: moderate, and rising. Quality operators are scarce, which cuts both ways. CareTrust needs them at least as much as they need CareTrust, and a genuinely strong regional operator can shop for capital among several REITs, private equity landlords and lenders. What CareTrust has built is preference rather than power — a reputation as a landlord that understands operations and structures deals collaboratively. Callister's description of the sourcing environment was telling: skilled nursing deal flow is now "predominantly off-market" and "relationship-driven," and he noted that the easy trade is gone — "you are typically not going to find a bread-and-butter sale-leaseback at a 9.5% yield with no creativity needed like you may have five years ago."[^12] That is a candid admission that terms have moved toward operators.

Bargaining power of suppliers: low. In a landlord's business the relevant suppliers are developers, sellers and capital providers. With new construction constrained and CareTrust holding both cash and investment-grade access, this force is not currently binding.

Threat of substitutes: moderate, and structurally interesting. Home health, outpatient rehabilitation and assisted living all divert patients who might once have entered a skilled nursing facility, and payers — particularly Medicare Advantage plans — actively push care to lower-cost settings and shorten lengths of stay. This is a genuine long-term pressure on skilled nursing volumes. The offset is acuity: as lower-acuity patients migrate out, the remaining skilled nursing population becomes sicker and more clinically complex, and for those patients there is no substitute short of a hospital bed at several times the cost. Skilled nursing is not being disrupted so much as pushed up the acuity curve.

Competitive rivalry: high. CareTrust competes with Omega Healthcare and Sabra Health Care in skilled nursing, with a broader field in senior housing, and increasingly with private capital everywhere. Rivalry is most intense precisely where CareTrust is trying to expand: Callister estimated that senior housing cap rates compressed by 50 basis points or more in the preceding six months, with Class A assets in primary markets carrying "a five handle."[^12]

Hamilton Helmer's 7 Powers

Helmer's framework is stricter than Porter's — it asks not whether an industry is good but whether a specific company holds a durable, hard-to-replicate advantage. Most of the seven do not apply here, which is itself informative. There are no meaningful scale economies in owning nursing home real estate, no network economies, no branded pricing power with tenants, and no process power in the manufacturing sense. Three warrant examination.

Counter-positioning: real, but narrower than claimed. The distinctive element in CareTrust's model is that it does not only buy buildings — it lends. The company originates mortgage and mezzanine loans to operators, frequently structured alongside or in anticipation of real estate acquisitions, generating high current yields while creating a proprietary funnel into future property ownership. In the first quarter of 2026, interest income from other real estate related investments and other income was approximately $22.0 million, and interest income from financing receivables was approximately $2.8 million — together about 17% of the quarter's total revenue.¹

Sedgwick was explicit about the discipline governing it: the strategy is to make loans "only if they include real estate acquisitions or we are confident that they will lead to real estate acquisitions."[^12] He also made a useful accounting clarification, noting that some transactions CareTrust considers economically to be sale-leasebacks are accounted for as financing receivables because of embedded purchase options — options struck nine or ten years out. "Technically, it will look like the loan book has grown more than it really will feel like it for the next ten years," he told analysts.[^12] That is a real accounting nuance investors should internalize before reading the loan book as a directional shift in strategy.

Is it counter-positioning in Helmer's strict sense — a business model incumbents cannot copy without damaging their existing business? Not quite. Other healthcare REITs do lend. What CareTrust has is a head start, deeper operator relationships, and a balance sheet that lets it move fast. That is an execution advantage, which is real but imitable.

Switching costs: genuinely high, and the most defensible power here. A skilled nursing operator cannot relocate. The license attaches to the building. Moving the business means finding a comparable licensed facility in the same market, transferring the license through a state change-of-ownership process that can take months, physically relocating a medically fragile resident population, re-credentialing with payers, and rebuilding hospital referral relationships. In practice this is close to impossible for a going concern. Master lease cross-collateralization compounds it. Once a tenant is in a CareTrust building under a master lease, it is in for the duration.

The important asymmetry, noted earlier, is that these switching costs bind the tenant far more than they protect the landlord in a default. High switching costs prevent voluntary departure; they do nothing about insolvency, and they lengthen the re-tenanting timeline when insolvency happens.

Cornered resource: partial. The Ensign relationship is the candidate. Ensign remains CareTrust's largest tenant, its leases carry a corporate guarantee, and the two companies share cultural and personal history. But the relationship is contractual, not exclusive — Ensign is free to lease from anyone, and increasingly owns real estate directly. What is closer to a genuine cornered resource is the accumulated operator network and underwriting knowledge: the ability to know, from experience, which regional operator can take over a troubled building in a specific market. That is difficult to buy and slow to build. It is also embodied in a small number of people, which makes it a key-person risk as much as an asset.

Where CareTrust actually sits versus peers

The peer comparison is where the analysis gets concrete.

On leverage, the gap is enormous and unambiguous. CareTrust's 0.6x against Omega's approximately 3.5x and Sabra's 5.04x is not a modest edge; it is a different capital structure philosophy.¹²³

On coverage, CareTrust's 2.25x stabilized triple-net EBITDAR compares favorably with Omega's roughly 1.57x core coverage.[^12]² Sabra's figures require care: it reports EBITDARM — after adding back management fees — at 2.46x for skilled nursing and 1.58x for leased senior housing, which is not directly comparable to an EBITDAR measure and reads higher by construction.³ Apples-to-apples, CareTrust's cushion appears materially the largest in the group.

On credit, the picture is less differentiated than the narrative implies. All three carry investment-grade ratings; Omega and Sabra both hold BBB-/Baa3-level ratings from multiple agencies.²³ CareTrust's balance sheet is dramatically stronger, but the ratings do not yet fully reflect that — partly a function of scale and track record.

On scale, CareTrust is a mid-cap in a sector with giants. At roughly $10 billion of market capitalization it sits above Sabra's approximately $5 billion but below Omega's roughly $14.8 billion, and is dwarfed by the diversified senior housing platforms — Welltower at roughly $173 billion and Ventas at roughly $47 billion.²³ Those giants generally do not compete for the mid-sized skilled nursing portfolios CareTrust targets, which is precisely the strategic space CareTrust occupies. But they are formidable in senior housing, which is where CareTrust is trying to grow.

The honest synthesis: CareTrust's advantages are real but concentrated in two places — an exceptional balance sheet and a genuine operator network — rather than distributed across a wide moat. Neither is permanent. A balance sheet advantage erodes the moment you use it. A relationship network depends on people. The framework verdict is that this is a very well-positioned company in a structurally decent industry, not an unassailable franchise.

---

↑ Back to Top

VIII. Risks, Stress Tests, and the Emerging Frontiers

If you wanted to construct the scenario that damages CareTrust most, you would not start with the REIT. You would start in a state legislature.

The risk that matters most

CareTrust does not employ a single nurse. It does not bill Medicare, negotiate with Medicare Advantage plans, or face a state survey. And yet every dollar of its rent originates in facility-level earnings that depend entirely on those things.

The transmission mechanism is worth spelling out, because it is the whole risk. Wage inflation and nursing shortages raise operator labor costs. Reimbursement rates, set administratively, do not automatically follow. The gap compresses facility EBITDAR. Compressed EBITDAR compresses rent coverage. Coverage that falls toward 1.0x means a tenant is earning exactly its rent and nothing more, and below 1.0x means it is funding the landlord out of capital rather than earnings — which is, by definition, temporary. Then comes the deferral request, the lease amendment, the operator transition, the vacancy period during the licensure transfer, and the impairment. CareTrust has run that sequence multiple times, and it takes years.

Today the cushion is large. At 2.25x, tenant earnings would need to fall by more than half before rent became unaffordable. That is genuine protection. It is also a portfolio average that conceals dispersion — averages always do — and it reflects a book bought at attractive bases in a favorable window.

The reimbursement overhang is the more structural concern. The provider tax phase-down beginning in fiscal 2028 constrains a mechanism states have used to fund nursing home rates.¹⁵ The effects are deferred, uneven across states, and partially offset by rural health funding and the removal of the staffing mandate. But the direction is unmistakable: federal support for the Medicaid financing architecture underpinning skilled nursing has become less generous, and CareTrust's tenants sit at the end of that chain. This is a genuine, legislated, multi-year headwind, and no amount of operator selection eliminates it.

Concentration, still

Ensign master leases represented approximately 23% of total annualized contractual rent at the end of 2025, and roughly 18% of full-year 2025 total revenue.⁴ That is a dramatic reduction from the 95% of 2014 — but it is still, by a wide margin, the largest single counterparty in the portfolio.

Fortunately, Ensign is a large, publicly traded, well-capitalized operator whose leases carry a corporate guarantee, which makes it a substantially better credit than any of the private regional operators that failed in the 2017–2022 period. But the concentration is unhedged. A serious operating or regulatory problem at Ensign would be a serious problem for CareTrust, and the fact that the two companies share cultural DNA and personnel history means their fortunes are more correlated than a simple tenant-landlord relationship would suggest. Related-party proximity of this kind — a former parent, staffed by alumni, as the largest tenant — is exactly what a governance-focused investor would probe.

Two frontier businesses, sized honestly

The senior housing operating portfolio. In a triple-net lease the landlord collects fixed rent. Under a RIDEA structure — permitted by 2008 tax legislation and universally referred to as SHOP — the REIT takes the operating economics of the property directly, hiring a third-party manager and booking resident fees as revenue and facility costs as expenses. The upside is uncapped: if occupancy and rates rise, the REIT captures it all. The downside is symmetric, and the earnings stream is far more volatile.

CareTrust has entered this business deliberately and slowly. Resident fees and services revenue was $3.85 million in the first quarter of 2026 — approximately 2.7% of the quarter's $142.8 million of total revenue.¹ As of the May 2026 call the portfolio comprised four communities.[^12] The most recent addition, in Prescott, Arizona, was roughly 110 units of assisted living with an estimated going-in year-one yield in the eight percent range, acquired with an operator CareTrust had known for years.[^12]

The underwriting standard Callister described is specific: a target of a low double-digit internal rate of return, an operator that is "a regional sharpshooter" with a proven track record and adequate reporting capability in that specific market, and a preference for being among the one, two or three best facilities in a market.[^12] What is notable is the discipline rather than the ambition. Sedgwick acknowledged on the call that competitors' aggressive underwriting has cost CareTrust deals, and framed its willingness to walk away as a function of not being forced into any one channel: "We have not painted ourselves into a corner with respect to having to do SHOP."[^12]

Sized at under 3% of revenue, SHOP is currently optionality rather than a thesis. It merits monitoring for two reasons: it is where cap rates are most compressed and therefore where a disciplined buyer is most likely to overpay, and it introduces genuine operating volatility into an income statement whose appeal has been its predictability. Investors should watch whether SHOP grows because attractive deals appear or because growth targets demand it.

The lending platform. Discussed above as a strategic funnel, it warrants a risk note here. At roughly 17% of first-quarter revenue, the interest-income streams are material.¹ They also carry credit risk of a different character than rent: an unsecured or mezzanine position behind other creditors in a distressed operator's capital structure recovers less than a landlord with the deed. Management's guidance assumption that $145 million of loans would be fully repaid through the remainder of 2026 illustrates the other feature of the book — it is short-duration and self-liquidating, which cuts both ways.[^12] Repayment is confirmation of underwriting, but it also means the income has to be continuously replaced.

The UK inflection

The largest strategic move in CareTrust's history was announced on March 11, 2025: a recommended cash acquisition of Care REIT plc, a London-listed care home landlord, at 108 pence per share — an equity value of approximately £448 million and a headline figure of $817 million.³⁸³⁹ The transaction was structured as a UK scheme of arrangement, sanctioned by the High Court, and completed on May 12, 2025 at a total transaction value of approximately $840.5 million, comprising roughly $595.4 million of cash for shares and about $245.1 million of assumed net debt.⁴⁰

What CareTrust bought was 132 UK care homes with approximately 7,500 beds, plus two NHS healthcare facilities, spread across England, Scotland and Northern Ireland and leased to fourteen operators.⁴⁰ The leases were long-term and triple-net with a weighted average remaining term of approximately 20.2 years and annual inflation-linked escalators, most carrying a 2% floor and a 4% cap, producing roughly $68.6 million of annual rental revenue at close.⁴⁰

Two features of that deal structure deserve emphasis. The twenty-year weighted average lease term is roughly double what a typical U.S. skilled nursing master lease carries. And the RPI-linked escalators with a floor and cap are structurally superior to CareTrust's U.S. escalators, which are capped at 2.5% with no floor — in an inflationary environment, the UK leases capture up to 4%, and in a deflationary one they never fall below 2%.

A year in, the integration appears to have gone better than planned. Asked on the call marking the one-year anniversary of closing how the portfolio was performing, Sedgwick said it was ahead of schedule in most cases, and made a specific admission about his own expectations: "I thought if we could do in 2026 a couple hundred million dollars of new investments in The UK, that would be great."[^12] The actual pace exceeded it — approximately $160 million of UK care homes closed year to date by early May 2026, with UK assets representing over half of the roughly $360 million forward pipeline.[^12] He attributed much of it to the inherited local team, and to the fact that Care REIT had been capital-constrained as a standalone company, leaving an unexploited pipeline.

On coverage, Sedgwick offered a comparison that clarifies why the UK assets are attractive: these are effectively senior housing assets, and when triple-net senior housing deals were still being written in the United States, lease coverage ran around 1.1x. The UK portfolio runs closer to 1.75x to 1.8x on an EBITDAR basis and north of 2.0x on an EBITDA basis.[^12]

The risks are genuine and mostly unhedged. Currency exposure is real — guidance explicitly assumes no material change in the sterling-dollar rate, and management has chosen partial natural hedging over financial hedging.[^12] The UK care home sector depends on local authority funding, which faces its own fiscal pressures, and CareTrust is new to the regulatory environment. Cross-border operating platforms have a long history of consuming more management attention than budgeted. That said, the evidence one year in — coverage holding, pipeline exceeding management's own stated expectations, team retained — is more supportive than not.

Asked whether CareTrust might apply a RIDEA structure to its UK portfolio as Omega has discussed doing, Sedgwick was measured: "I think there will be a time when that opportunity presents itself for us, and we should be ready to do that."[^12] Non-committal, but it flags a possible future strategic direction.

---

↑ Back to Top

IX. The Investment Story Spine: Bull vs. Bear

Strip away the narrative and one question remains: does CareTrust have a credible answer to why it wins from here, and what would prove that answer wrong?

Why it might win

The demographic argument, stated carefully. The population aged 80 and above is entering its steepest growth phase in American history as the baby boom cohort ages into the years when skilled nursing and assisted living become necessary. Meanwhile supply has contracted — facilities closed during and after the pandemic were not replaced, and Certificate of Need regimes plus prohibitive construction economics have kept new development minimal. Demand rising into constrained supply is, in principle, the most durable tailwind a real estate owner can have.

Sedgwick offered a specific framing on the call: skilled nursing occupancy has climbed steadily since bottoming in 2021, currently sits in the 80% range across CareTrust's portfolio, and in his view "five to seven years from now, I think it is going to be dramatically different."[^12] The caution to attach is that demographics are slow, and reimbursement is fast. A favorable twenty-year demand curve does not protect a tenant from a bad Medicaid budget in a single year. Demographics set the ceiling; policy sets the floor.

The optionality argument, which is stronger. This is the more concrete piece of the bull case. Running at 0.6x leverage with investment-grade access and well over $1.7 billion of immediately available capital, CareTrust holds an option that peers running at four or five turns simply do not: the ability to buy aggressively in a market where others cannot.[^12]¹ Distressed real estate is cheapest exactly when credit is tightest. A landlord with no maturity wall before 2028 and untapped debt capacity is positioned to be a buyer at that moment rather than a forced seller. Optionality of that kind does not show up in current earnings, which is precisely why it tends to be underpriced.

The execution evidence. Year to date through early May 2026, CareTrust closed approximately $1.1 billion of investments at a blended stabilized yield of roughly 8.9% — approximately $705 million of U.S. skilled nursing and senior housing triple-net, roughly $225 million of U.S. loans, approximately $160 million of UK care homes, and the remainder SHOP.[^12] That followed $1.8 billion deployed in 2025 at an 8.6% blended stabilized yield.⁴ Sustaining yields near nine percent while deploying at that pace, in a market management itself describes as competitive, is the best available evidence that the sourcing advantage is real rather than rhetorical.

Why it might not

The multiple is the machine. This is the central vulnerability, and it deserves to be stated without hedging. CareTrust trades at a premium to its peer group — low twenties on 2026 guided FFO against a mid-teens multiple for Omega on its 2026 AFFO guidance.² That premium is the source of the cheap equity that funds the accretive acquisitions that produce the growth that justifies the premium.

It is a self-reinforcing loop, which means it can also self-reinforce in reverse. A meaningful de-rating — triggered by a tenant failure, a reimbursement shock, a sector-wide multiple compression, or simply a rotation out of defensive real estate — would raise the cost of equity, narrow the spread, slow accretion, and slow growth. The company would remain perfectly solvent; it would just stop compounding at the rate that earned it the premium. Investors buying at a premium multiple are, whether or not they frame it that way, underwriting the persistence of that premium.

The reinvestment problem. Growing FFO per share in the mid-teens off a base that now exceeds $10 billion requires deploying more than a billion dollars a year into assets yielding close to nine percent, sourced from operators good enough to sustain coverage above two times. Both constraints are binding, and management's own commentary suggests they are tightening — the disappearance of the easy 9.5% sale-leaseback, aggressive competing underwriting in senior housing, cap rate compression of 50 basis points or more in six months.[^12]

There are three ways this resolves. CareTrust maintains discipline and growth decelerates, which is honest but compresses the multiple. It maintains growth by accepting lower yields, which narrows the spread. Or it maintains both by accepting weaker operators — which would not show up for several years, and would show up as exactly the pattern the company lived through with Pristine, Trillium and Metron. The third is the scenario worth watching for, and the leading indicator is coverage on newly acquired assets, not the headline portfolio average.

The activist's angle. A skeptical investor would press on several points. Compensation tied to FFO per share and relative TSR rewards deployment volume and market sentiment, neither of which measures underwriting quality; the true test of a 2026 acquisition arrives around 2030. A six-person board with the founder returned and a leadership team drawn heavily from one former parent's alumni network raises reasonable questions about independent challenge. The company is simultaneously scaling three distinct businesses — U.S. triple-net, a lending platform, and SHOP — plus a cross-border UK operation, all while integrating a large volume of new assets. Sedgwick's own praise on the call for an accounting team that has "shouldered an enormous load onboarding a massive number of new assets and operators across the US and The UK" is a compliment that doubles as a description of operational strain.[^12] And a persistent pattern of guiding low and raising, while shareholder-friendly in effect, is worth monitoring for what it says about how targets are set.

None of these is disqualifying. All are the correct questions to be asking of a company growing this fast.

What to actually track

Three metrics carry most of the signal. Everything else is commentary.

First, EBITDAR lease coverage — and specifically its trend and its dispersion, not just its level. This is the leading indicator of every problem CareTrust has ever had. A high average conceals weak tenants; the useful exercise is watching whether the average is drifting and whether the company begins disclosing more assets as non-stabilized. Coverage deteriorates for several quarters before rent does.

Second, the spread between acquisition yields and cost of capital. Not either number alone. If blended stabilized yields drift down while the FFO yield drifts up, the accretion engine is narrowing regardless of how much capital gets deployed. This is the metric that determines whether volume translates into per-share growth.

Third, Ensign concentration as a share of annualized contractual rent. It captures both diversification progress and — as the 2022 uptick demonstrated — hidden trouble in the non-Ensign book. Concentration rising when acquisitions are running at record pace would signal that assets are being shed somewhere, and that is worth understanding before the impairment lands.

---

↑ Back to Top

X. Playbook, Lessons, & Epilogue

Twelve years is long enough to draw conclusions. Three of them generalize well beyond one healthcare REIT.

Lesson 1: The spin-off as value realization

The Ensign separation is a case study in a specific kind of corporate arbitrage: the same assets, held by different owners, get valued on different multiples.

Ensign's real estate, sitting inside an operating company, was valued by investors analyzing operating margins, census trends and reimbursement risk. Moved into a standalone REIT with contractual leases, the same buildings were valued by real estate investors on cap rates and lease duration. Nothing about the physical assets changed. The buyer pool did.

What made this particular separation work better than most was that neither entity was crippled by it. Ensign received roughly $221 million of proceeds and shed the capital intensity of property ownership, keeping the operating business it was genuinely good at.⁹ CareTrust received a portfolio with a guaranteed lease stream at roughly 2x coverage and a clear mandate.⁹ The frequent failure mode in spin-offs — loading one entity with the debt and the other with the assets — was largely avoided.

The subtler lesson concerns what CareTrust inherited beyond property. Spinning out real estate is easy; anyone can transfer deeds. What was harder to replicate was the accumulated knowledge of how nursing homes actually work, and that traveled with the people. A dozen years on, the operating heritage remains the company's most-cited differentiator. The buildings were the transaction. The knowledge was the asset.

Lesson 2: Operational competence as underwriting moat

The deeper argument this history supports is that in specialty real estate, financial underwriting alone is insufficient.

A purely financial buyer evaluating a nursing home portfolio can model cap rates, lease terms, coverage ratios, and reimbursement scenarios. What is much harder to model from a spreadsheet is whether a specific operator can staff a specific building in a specific labor market, whether a state survey team is about to arrive with concerns, whether the local hospital's discharge planners trust the facility, and whether the administrator is the kind who fixes problems or hides them.

CareTrust's record on this is genuinely mixed and should be read as such. The company's early tenant selection was not obviously better than a financial buyer's — four significant relationships from the 2015–2018 vintage required rescue. What operating knowledge did deliver was speed and effectiveness in the workout, which turned out to matter enormously. Knowing which regional operator can walk into a Dayton facility next month, and having the relationship to make that call, is worth more than any amount of scenario modeling once a tenant fails.

The generalizable version: in asset classes where the tenant's business is complex and specialized, the landlord's real competence is not selection but recovery. Defaults are not a tail risk in skilled nursing; they are a recurring cost of doing business. The landlords who survive are the ones with the shortest re-tenanting cycles.

Lesson 3: Low leverage as a strategic weapon

The most counterintuitive lesson is about the balance sheet, and it inverts conventional REIT wisdom.

The textbook says a REIT should lever to a prudent target and stay there, because debt is cheaper than equity and unused borrowing capacity is idle capital. By that standard CareTrust at 0.6x is dramatically inefficient — it could add several billion dollars of debt tomorrow without approaching its own stated target.

But the textbook prices only the cost of capital, not the option embedded in flexibility. Through the 2022–2023 rate shock, CareTrust had no maturity wall and no refinancing crisis. It could pause acquisitions without distress, clean up its tenant book, and wait. When the market improved, it could deploy at a pace far exceeding its own historical run rate — approaching a billion dollars in a single quarter in early 2026 — because it never had to spend a year fixing its capital structure.[^12]

The catch, and it is a real one, is that this advantage is consumed by use. Every turn of leverage CareTrust adds moving toward its 4.0x to 5.0x target is a turn of optionality spent. Management has said it intends to get there eventually, and Bunker has signaled an inaugural bond issuance is under active consideration.[^12] The company that emerges at four turns of leverage will be a larger, more conventional REIT, and the balance sheet will no longer be the differentiator. Whether the operator network alone can sustain a premium valuation at that point is an open question, and probably the most important one in the long-term investment case.

Epilogue

In July 2026, CareTrust REIT is roughly $10 billion of market value, more than four hundred properties across thirty-two American states and the United Kingdom, and a growth rate that most REITs abandoned a decade ago. It carries dual investment-grade ratings, essentially no net debt, and rent coverage roughly forty percent above its nearest large-cap comparable.¹[^12]³⁵³⁶

It also carries a premium multiple that presumes continued execution, a largest tenant that is also its former parent, a business model dependent on reimbursement decisions made in fifty state capitals, and an acquisition pace that must be sustained through a market its own executives describe as increasingly competitive.

The demographic wave is genuinely coming — the population that needs skilled nursing is growing faster than the supply of licensed beds, and the arithmetic of that has not been seriously disputed. Whether CareTrust captures it depends on holding underwriting discipline while deploying more capital than at any point in its history, integrating a cross-border platform, and scaling an operating-risk business in senior housing, all at once.

The company was built by people who ran nursing homes. Whether that heritage is a durable advantage or a good story that happened to coincide with a favorable decade in capital markets is a question the next several years will answer, and the answer will show up first in a coverage ratio.

---

References

1. CareTrust REIT Announces First Quarter 2026 Operating Results; Increases 2026 Guidance — CareTrust REIT, Inc., 2026-05-07 ↩↩↩↩↩↩↩↩↩↩↩↩↩

2. Omega Reports First Quarter 2026 Results and Recent Developments — Omega Healthcare Investors, 2026 ↩↩↩↩↩↩↩

3. Sabra Health Care REIT First Quarter 2026 Supplemental Information (Form 8-K Exhibit 99.2) — Sabra Health Care REIT, Inc., 2026 ↩↩↩↩↩

4. Annual Report on Form 10-K for the Year Ended December 31, 2025 — CareTrust REIT, Inc., 2026-02-12 ↩↩↩↩↩↩↩↩↩↩↩↩

5. CareTrust REIT, Inc. Announces Completion of Spin-Off From The Ensign Group, Inc. — GlobeNewswire, 2014-06-03 ↩↩

6. The Ensign Group, Inc. Annual Report on Form 10-K (Fiscal 2017) — The Ensign Group, Inc. ↩↩↩↩↩

7. Quiet Men: Ensign Group Father, Son Power Growth — Orange County Business Journal ↩↩

8. CareTrust REIT Appoints Gregory K. Stapley to Board of Directors — CareTrust REIT, Inc., 2025-10-24 ↩↩

9. CareTrust REIT, Inc. Annual Report on Form 10-K (Fiscal 2015) — CareTrust REIT, Inc. ↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩

10. CareTrust and Ensign Announce Pricing of $260 Million of Senior Notes by Subsidiaries of CareTrust — The Ensign Group, Inc., 2014-05-16 ↩

11. CareTrust REIT, Inc. SEC Filings Database (CIK 0001590717) — SEC EDGAR ↩↩

12. A Look at Nursing Facility Characteristics — KFF, 2025 ↩

13. Federal Court Strikes Down CMS Nursing Home Staffing Mandate — Faegre Drinker, 2025-04 ↩

14. CMS Repeals Minimum Staffing Requirements for Skilled Nursing, Long-Term Care Facilities — American Hospital Association, 2025-12-02 ↩

15. The One Big Beautiful Bill Act Explained: A Detailed Review of Key Changes for the Healthcare Industry — King & Spalding, 2025 ↩↩↩

16. Certificate of Need State Laws — National Conference of State Legislatures, 2025-04-29 ↩↩

17. Certificate-of-Need Laws: How They Affect Healthcare Access, Quality and Cost — Mercatus Center, 2021-05-21 ↩

18. CareTrust REIT Completes Acquisition of 14-Facility Liberty Portfolio — CareTrust REIT, Inc., 2015-10 ↩

19. CareTrust REIT Announces Addition of Two New Provider Relationships — CareTrust REIT, Inc., 2018 ↩

20. CareTrust REIT Completes Sale of Ohio Skilled Nursing Facilities — CareTrust REIT, Inc., 2022-09-30 ↩

21. CareTrust REIT Completes $52 Million Sale of 7-SNF Portfolio in Ohio — McKnight's Senior Living, 2022 ↩

22. Quarterly Report on Form 10-Q for the Period Ended September 30, 2021 — CareTrust REIT, Inc. ↩

23. Assisted Living Facilities and Care Quality Concerns — HuffPost, 2021 ↩

24. CareTrust REIT Announces First Quarter 2022 Operating Results — GlobeNewswire, 2022-05-05 ↩

25. CareTrust REIT Announces First Quarter 2020 Operating Results — GlobeNewswire, 2020-05-07 ↩

26. CareTrust REIT, Inc. 2022 Proxy Statement (Schedule 14A) — CareTrust REIT, Inc. ↩↩↩

27. CareTrust REIT Announces David Sedgwick to Succeed Greg Stapley as Chief Executive Officer — GlobeNewswire, 2021-12-10 ↩

28. CareTrust REIT Announces Changes to the Board of Directors — Business Wire, 2022-06-30 ↩↩

29. CareTrust REIT Announces James Callister to Succeed Mark Lamb as Chief Investment Officer — CareTrust REIT, Inc., 2022-11-28 ↩

30. CareTrust REIT Announces the Planned Retirement of Bill Wagner and Names Derek Bunker CFO Successor — CareTrust REIT, Inc., 2025-09-23 ↩↩

31. CareTrust REIT Positions for Continued Growth with New $500 Million Term Loan and New Hires — CareTrust REIT, Inc., 2025 ↩↩

32. CareTrust REIT Appoints Gregory K. Stapley to Board of Directors — Business Wire, 2025-10-24 ↩

33. CareTrust REIT, Inc. Announces Pricing of Upsized Public Offering of Common Stock — CareTrust REIT, Inc., 2025-08-12 ↩

34. CareTrust REIT, Inc. Announces Pricing of Upsized Public Offering of Common Stock — Business Wire, 2026-05-18 ↩

35. CareTrust REIT Receives Investment Grade Rating Upgrade from Fitch Ratings — Business Wire, 2025-05-28 ↩↩

36. CareTrust REIT Receives Investment Grade Rating Upgrade from Moody's — Business Wire, 2026-04-27 ↩↩

37. CareTrust REIT Raises Quarterly Dividend to $0.39 per Share — CareTrust REIT, Inc., 2026 ↩

38. CareTrust REIT, Inc. Announces $817 Million Recommended Cash Acquisition of Care REIT plc — Business Wire, 2025-03-11 ↩

39. Court Clears CareTrust's £448M Takeover of UK REIT — Law360, 2025 ↩

40. CareTrust REIT Closes Acquisition of Care REIT plc, Enters UK Market — CareTrust REIT, Inc., 2025-05-12 ↩↩↩